Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M111334200 on January 22, 2002

J. Biol. Chem., Vol. 277, Issue 13, 11513-11520, March 29, 2002
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/13/11513    most recent
M111334200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Haynes, C. A.
Right arrow Articles by Rodgers, D. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Haynes, C. A.
Right arrow Articles by Rodgers, D. W.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Structures of Nitroreductase in Three States

EFFECTS OF INHIBITOR BINDING AND REDUCTION*

Chad A. HaynesDagger , Ronald L. Koder§, Anne-Frances MillerDagger §, and David W. RodgersDagger ||

From the Dagger  Department of Molecular and Cellular Biochemistry and Center for Structural Biology and the § Department of Chemistry, The University of Kentucky, Lexington, Kentucky 40536

Received for publication, November 28, 2001, and in revised form, January 22, 2002

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES

The crystal structure of the nitroreductase enzyme from Enterobacter cloacae has been determined for the oxidized form in separate complexes with benzoate and acetate inhibitors and for the two-electron reduced form. Nitroreductase is a member of a group of enzymes that reduce a broad range of nitroaromatic compounds and has potential uses in chemotherapy and bioremediation. The monomers of the nitroreductase dimer adopt an alpha +beta fold and together bind two flavin mononucleotide prosthetic groups at the dimer interface. In the oxidized enzyme, the flavin ring system adopts a strongly bent (16°) conformation, and the bend increases (25°) in the reduced form of the enzyme, roughly the conformation predicted for reduced flavin free in solution. Because free oxidized flavin is planar, the induced bend in the oxidized enzyme may favor reduction, and it may also account for the characteristic inability of the enzyme to stabilize the one electron-reduced semiquinone flavin, which is also planar. Both inhibitors bind over the pyrimidine and central rings of the flavin in partially overlapping sites. Comparison of the two inhibitor complexes shows that a portion of helix H6 can flex to accommodate the differently sized inhibitors suggesting a mechanism for accommodating varied substrates.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES

Nitroaromatic compounds are pervasive pollutants whose toxicity is generally the result of their enzymatic reduction to more reactive species (1-3). There is considerable interest in the flavin-containing nitroreductases that catalyze the reductive activation of nitrated aromatics, because of their central role in mediating nitroaromatic toxicity (4-9), their potential use in bioremediation (1-3, 10), and their utility in activating prodrugs in directed anticancer therapies (11, 12).

The nitroreductase from Enterobacter cloacae (NR)1 catalyzes two-electron reduction of a variety of nitrated aromatics as well as quinones and flavins (13-16). Indeed, this enzyme was first isolated from bacteria growing in a weapons storage dump, and can reduce trinitrotoluene (80). NR reduces nitrobenzene to the corresponding hydroxylamine and derives reducing equivalents from reduced nicotinamide adenine dinucleotide (NADH), reduced nicotinamide adenine dinucleotide phosphate (NADPH), or other nicotinamides (15) by means of a flavin mononucleotide cofactor (FMN) (13, 14).

NR follows ping-pong bi-bi kinetics, and its FMN groups cycle between the oxidized neutral and reduced anionic states with an Eox/hq of -190 mV, near that of free FMN (81). Single-electron redox chemistry and associated formation of the semiquinone are not stabilized. This results in NR's activity being "oxygen-insensitive," in that the enzyme does not readily transfer one electron to molecular oxygen to form the superoxide radical (13, 15).

Several other FMN-containing oxidoreductases have been identified that have similar broad substrate specificity ranges and also do not stabilize the semiquinone state of the bound flavin. They are homodimers that share a similar fold and key amino acids, although the amino acid identities conserved over the whole group are few (17). The minor O2-insensitive nitroreductase of Escherichia coli (NTR or NfsB), shares 88% sequence identity with NR (18). The major NAD(P)H:FMN oxidoreductase of Vibrio fischeri (FRase I) shares only 33% sequence identity (17, 19) whereas NADH oxidase from Thermus thermophilus (NOX) is even more remotely related (20, 21). Additional homologues include the major O2-insensitive nitroreductase of Escherichia coli (NfsA) (22) and NADPH:flavin oxidoreductase of Vibrio harveyi (FRP) (23). Crystal structures have been deposited and/or published for several members of this family in the oxidized state, and all show an FMN bound at the interface between monomers in each of two symmetry-related but independent active sites (24-29).2

We have determined crystal structures of oxidized NR in complex with two different inhibitors of the first half reaction as well as the crystal structure of the reduced enzyme.3 This work represents the most extensive comparison of states yet published for an NR homologue and includes the first crystal structure of one of these enzymes in the reduced state. Details of the flavin conformation and inhibitor binding interactions provide novel insights into the bases for the oxygen insensitivity and substrate specificity range of this important family of enzymes.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES

Protein Crystallization-- E. cloacae nitroreductase was overexpressed in Escherichia coli and purified according to published methods (30). The purified enzyme was stored at a concentration of 4.75 mg/ml in 50 mM KH2PO4 (pH 7), 0.02% (w/v) NaN3. The protein buffer was exchanged with 10 mM HEPES (pH 7) and 50 mM KCl prior to crystallization.

Crystals of oxidized NR were grown by hanging-drop vapor diffusion at 4 °C against well solution containing 100 mM homopipes (pH 4.8), 25 mM acetate, and 15% PEG-4000. They grew to full size (0.5 × 0.5 × 0.1 mm) within 30 days. Prior to data collection, crystals were dialyzed against cryoprotectant solution containing 100 mM HEPES (pH 4.8), 25 mM sodium acetate, 25% PEG-4000, and 18% glycerol for 16 h. The crystals were mounted in nylon loops and flash cooled by plunging into liquid nitrogen (31).

Formation of the Benzoate Complex-- Oxidized NR crystals were dialyzed against cryoprotectant solution containing 100 mM HEPES (pH 4.8), 600 mM sodium benzoate, 25% PEG-4000, and 18% glycerol for 20 h prior to flash cooling.

Chemical Reduction of Oxidized Crystals-- A fresh solution of sodium dithionite was added to cryoprotectant, and 25 µl of the resulting solution was gently mixed with oxidized NR crystals in 25 µl of cryoprotectant. After ~10 min, 25 µl of cryoprotectant buffer was removed and replaced with 25 µl of cryoprotectant buffer containing dithionite. This procedure was repeated two more times. The crystals lost their deep yellow color over the course of the treatment. They were then immediately flash cooled and stored in liquid nitrogen prior to data collection.

Data Collection and Structure Determination-- Crystals were held at 115 K for data collection on a CuKalpha source with an R-AXIS IV++ image plate detector. Data were reduced with the HKL (32) and CCP4 packages (33). The crystal and data parameters are given in Table I. In all crystals there are four monomers, or two dimers, in the asymmetric unit.

                              
View this table:
[in this window]
[in a new window]
 
Table I
Summary of crystallographic data

Initial structures were determined by molecular replacement using the CNS software package (34) and the coordinate set of unliganded nitroreductase2 as a search object. Geometry restraint files for acetate and benzoate were taken from the HIC-UP site (35). Initial restraint files for FMN were also taken from the HIC-UP site and modified to reflect theoretical values for oxidized and reduced flavin (36). Individual weighting values for the FMN geometry parameters were adjusted to give stable refinement while still allowing the flavin to adopt the correct conformation (as judged by omit density and tests with low geometry weights and noncrystallographic symmetry restraints on the FMN groups to stabilize refinement). Initial manual rebuilding was followed by simulated annealing refinement in CNS and subsequent cycles of manual rebuilding (37), addition of ordered solvent, and energy minimization. The resolution and quality of the data were sufficient for refinement without applying noncrystallographic symmetry restraints. Final refinement parameters are given in Table II.

                              
View this table:
[in this window]
[in a new window]
 
Table II
Summary of refinement


    RESULTS AND DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES

Flavin Mononucleotide Binding and Geometry in the Oxidized State-- NR (13, 14) and homologous enzymes (17, 18, 21, 38, 39) are dimers of 24-kDa subunits that share a characteristic alpha +beta fold (Fig. 1). A central sheet consists of four antiparallel strands, with a fifth, parallel strand arising from the C terminus of the other dimer subunit. Surrounding the sheet are two large helices on one side, three smaller helices on the other, and two helices that pack against one end of the sheet. Several small helices or helical turns are also present. The FMN prosthetic groups bind in deep pockets at the dimer interface and interact with elements from both monomers (see Fig. 2 for FMN structure and numbering). In NR, each flavin group packs up against one end (S3) of the central sheet and is surrounded by helices H4 and H7. Helix H6 and the loop between H2 and S1 (particularly residues 36-43) from the other subunit form a cap over the cofactor binding site. H7 from that monomer also contributes to the pocket.


View larger version (30K):
[in this window]
[in a new window]
 
Fig. 1.   Overview of the nitroreductase fold. a, ribbons diagram of the nitroreductase dimer showing the location of the flavin mononucleotide prosthetic groups (yellow bonds) at the dimer interface. The bound acetate molecule is shown with red bonds. b, topology of nitroreductase. Panel a was prepared with the program RIBBONS (78).


View larger version (12K):
[in this window]
[in a new window]
 
Fig. 2.   Chemical structure and atom numbering of the flavin mononucleotide prosthetic group of nitroreductase. a, oxidized flavin; b, fully reduced anionic form of the flavin. In both panels, the flavin is oriented as if viewing the re face. The other orientation is referred to as the si face.

Affinity for the FMN cofactor is high (10 nM), and within this structural family, binding typically involves extensive interactions with the protein, some of which are conserved or similar across the group. The polar groups in the isoalloxazine ring of FMN typically participate in a number of hydrogen bond interactions with protein, and seven hydrogen bonds with the flavin are present in the NR crystal structure. One group of contacts involves the N1, O4, and N3 positions of the ring system, including donation of a hydrogen bond by the backbone amide of Glu-165 to N5, which is thought to be the site of hydride transfer (40). This set of interactions is remarkably well conserved across the entire group of homologues, although the identities of some residues vary. One interacting residue, Gly-166 in NR, is absolutely conserved within the group. Main-chain torsion angles for this residue are either near the beta -strand region of the Ramachandran plot (NR, NTR, FRase I, and NOX) or in the helical region (FRP and NfsA), both allowed positions for residues with side chains. Glycine is not, therefore, required at this position because of its greater backbone flexibility. Instead it may be conserved, because any side-chain atoms would intrude on space over the flavin reserved for substrate binding.

The other group of contacts with the isoalloxazine ring involves the O2 and in some cases N1 atoms, which largely interact with basic residues. In NR and NTR, for example, there are two strong interactions between O2 of the pyrimidine ring and lysines 14 and 74. Unlike the first set of contacts, however, these interactions vary substantially across the group of related enzymes. This variation within the second group of interactions is particularly interesting, because the anionic forms of both the one- and two-electron reduced flavins develop resonance stabilized negative charge at the N1-C2=O2 locus. Positive electrostatic potential from the protein near this region is a common feature of flavoenzymes, and the degree of positive charge is thought to be a strong factor in determining the redox potential of the system (40, 41). Variations in the exact nature of the contacts within the related group may then modulate the redox characteristics of the enzymes.

In each of the NR homologues, the carbonyl oxygen from a residue located on the si side of the flavin interacts with the pi  system at the central ring (Fig. 3). The carbonyl oxygen is contributed by a proline residue (Pro-163) in NR. It is positioned about 2.8 Å from the plane of the central ring and almost directly below its center point, where the protein backbone runs across the short axis of the flavin. The rigid proline residue in NR is not required to place the carbonyl group in the observed orientation. Although both NTR and NOX also have prolines at this position, FRase I has a threonine (Thr-163), and NfsA and FRP both have tyrosines. As noted by others (42), this interaction of an electronegative group with the central region of the isoalloxazine ring is found in a number of flavin-containing proteins.


View larger version (54K):
[in this window]
[in a new window]
 
Fig. 3.   Conformation and electron density for the FMN prosthetic group of nitroreductase. Edge-on view of the flavin showing the electron donor-pi interaction with the carbonyl oxygen of Pro-163. 2Fo - Fc density was averaged over the four independent molecules in the crystal asymmetric unit and displayed at two times the r.m.s. deviation of the map. The PDBVIEWER software (79) was used to create the figures.

The extensive interactions with the protein have a substantial effect on the conformation of the flavin. Both structural (43-49) and computational studies (36, 50-53) suggest that the free isoalloxazine ring system is close to planar in the oxidized state. In contrast, the flavins in the oxidized NR structures are curved along their lengths (Fig. 3). This distortion of the isoalloxazine has been termed butterfly bending to indicate a rigid motion of the two end rings about the N5-N10 axis. Both oxidized structures have the same overall bend of ~16°, with an r.m.s. difference in atomic positions of only 0.03 Å. Although there have been other flavoproteins reported with similar or even more extreme butterfly bends, they are rare, probably comprising 10% or less of the reported structures (54). Crystallographic thermal factors indicate low mobility of the flavin, with an average on all atoms of 12.5 Å2 for the oxidized acetate complex and 11.4 Å2 for the oxidized benzoate complex. The flavin is rigidly fixed by interactions with the protein and is not disturbed by binding different ligands over the re face.

It is likely that the geometry of the binding site plays a role in inducing the bent flavin conformation. The dimethylbenzene ring and a portion of the central ring are held tightly by structural elements on both faces. Hydrogen bonding groups interacting with the pyrimidine end of the isoalloxazine arise largely from the si side of the flavin, the same direction as the bend. On binding, then, the interactions with the pyrimidine ring are optimized at the cost of distorting the flavin. Bending of the flavin cofactor has also been attributed to steric aspects of the binding site in pyruvate oxidase (55), NADH oxidase (24), and in the reduced form of thioredoxin reductase (54).

In addition, specific features of the protein-flavin interaction in NR may affect flavin conformation. Among the NR homologues, the interactions that stand out are: 1) the presence of an electron rich group (main-chain carbonyl oxygen in NR and its homologues) interacting with the pi  system of the isoalloxazine at or near the central ring, 2) a hydrogen bond donor (main-chain amide in NR and homologues) interacting with N5 of the flavin, 3) the presence of positively charged residues near the N1-C2=O2 locus, and 4) the absence of parallel pi -pi stacking of aromatic side chains with the flavin. To assess the significance of these interactions, we examined 54 flavoproteins in a unique data set identified by Lennon et al. (54) for the presence of each of the four interactions and grouped the data into three bend angle classes: 0-5°, 5-10°, and >10°. Only parallel stacking of the flavin with an aromatic group from the protein was clearly correlated with bend angle, being absent in all twelve structures in the highest bend angle group. All of the surveyed aromatic interactions involve stacking, at least in part, with the central ring of the isoalloxazine. Because this ring becomes significantly nonplanar and the pi  system weakens in a highly bent flavin, the presence of a stacking interaction would tend to inhibit butterfly bending. Two of the other features, basic amino acid residues interacting with N1-C2=O2 and a hydrogen bond donated to N5, are more prevalent in the large bend angle group, but the small size of the sample limits the significance of this observation. The prevalence of H-bond donor interactions is particularly attractive, because they might directly affect the resonance characteristics of the central ring, which accounts for a large portion of the distortion associated with butterfly bending.

Inhibitor Binding-- In earlier work (15), we demonstrated that small negatively charged organic molecules such as acetate and benzoate are inhibitors of nitroreductase. They act competitively with substrate (NAD(P)H) for the first half reaction, flavin reduction, and uncompetitively in the second half reaction, reduction of the nitroaromatic. The binding of these inhibitors is relatively weak with overall Ki values of 0.1 mM for benzoate and 9 mM for acetate, for example (15).

In the two oxidized NR crystal structures, both acetate and benzoate bind over the pyrimidine and central rings of the isoalloxazine system in partially overlapping sites (Fig. 4). The central carbon of the acetate is located above a point midway between flavin atoms C4a and C10a, so that the bulk of the molecule lies over the central ring. The carboxylate group of benzoate is in a similar position, but shifted over toward the pyrimidine ring of the flavin. The benzene ring is not stacked over the isoalloxazine pi  system. Rather it extends out over O4 of the flavin and the gap between the pyrimidine and central rings. Both inhibitors hydrogen bond to the O2' oxygen of the ribose moiety, and the same carboxylate oxygen of each inhibitor interacts with the main-chain NH of Thr-40, which is located in the loop between H2 and S1 that helps form the flavin binding site. The other carboxylate oxygen of acetate interacts with two water molecules, one of which also hydrogen bonds to O2' of the ribose. The corresponding benzoate oxygen is shifted toward N1 of the flavin, altering the water structure relative to the acetate complex. It interacts with only a single water molecule, which is not equivalent to either of the acetate complex solvent molecules. In general, the presence of a negatively charged group seems to define this class of NR inhibitors (15). Because both acetate and benzoate bind with their carboxylate groups near lysines 14 and 74, electrostatic interaction with these residues may be a principle reason for the binding of these inhibitors.


View larger version (40K):
[in this window]
[in a new window]
 
Fig. 4.   Inhibitor binding to nitroreductase. a, binding of acetate over the isoalloxazine ring system; b, binding of benzoate over the isoalloxazine ring system. Averaged omit density for both inhibitors is contoured at three times the r.m.s. deviation of the map.

Both acetate and benzoate are positioned ~3.6 Å above the flavin, making van der Waals contacts with a number of ring atoms. The acetate methyl group also contacts atoms in protein residues, in particular Ogamma of Ser-40, Cgamma of Thr-41, and the side-chain atoms of Phe-124, and these interactions presumably contribute to binding affinity. The protein residues and flavin define a cavity that is only large enough to accept the acetate methyl group. Binding of benzoate, therefore, requires rearrangement to accommodate this much larger inhibitor. The cavity is enlarged almost exclusively by side-chain and main-chain shifts in helix H6 (Fig. 5), the large helix that is positioned over the re face of the isoalloxazine ring. The movement occurs primarily at two residues, Phe-124, which directly interacts with the bound inhibitor, and Tyr-123, which contacts the other side of the Phe-124 side chain. For both residues, the Calpha atoms shift about 0.6 Å between the two complex structures. Changes in the main-chain torsion angles and chi1 side-chain torsion angles amplify this movement, so that Phe-124 shifts by 2.5 Å at its distal ring carbon. The tighter binding of benzoate over acetate may be due in large part to the favorable interaction (56) between its aromatic ring and the phenyl group of Phe-124.


View larger version (30K):
[in this window]
[in a new window]
 
Fig. 5.   Shifts in helix H6 to accommodate the larger benzoate inhibitor. H6 bonds are blue in the acetate structure and red in the benzoate complex. The density and structure of the bound benzoate are shown.

While preparation of this paper was in progress, the structure of NTR with bound nicotinic acid, a first half reaction substrate analogue, was published (29). Nicotinic acid binds in the same position and orientation as the benzoate in the NR complex. Structures of flavoenzymes with pyridine nucleotide bound in positions consistent with hydride transfer (57-59), also show the nicotinamide group stacking over either the re or si face of the isoalloxazine system. In NR then the organic acid inhibitors overlap the reducing substrate binding site, consistent with their competitive inhibition of the first half reaction.

Substrates for the second half reaction, the oxidizing substrates, probably also bind over the re face of the reduced flavin to effect hydride transfer. This location of the nitroaromatic binding site is consistent with the ping-pong kinetic mechanism of NR (15). Also, mutation of the phenylalanine in NfsA equivalent to Phe-124, which interacts with bound organic acids, affects nitroaromatic substrate specificity (60). NR is capable of reducing a variety of nitroaromatics and isoalloxazine derivatives (15), and other members of this structural group also show broad substrate specificity (18, 20, 22, 61). If the organic acid inhibitors bind at the same site as oxidizing substrates, then the crystal structures with the inhibitors suggest a mechanism for accommodating substrates of different size. The plasticity of helix H6, demonstrated by its response to the two different organic acid inhibitors, creates a variable volume cavity capable of conforming to different bound substrates. The helices equivalent to H6 in crystal structures of other members of the group also show elevated thermal factors and variability in position indicative of inherent plasticity (24-29). These enzymes probably use a similar mechanism for adapting to different substrates. Depending on the type and size of oxidizing substrate, other nearby aromatic residues (Tyr-68, Phe-70, Tyr-123) may also participate in the binding interaction. Interestingly, the identity of these residues varies among the related flavoenzymes, suggesting that they may play a role in determining substrate preferences (15, 18, 20, 22, 61).

The Reduced Form of the Enzyme-- Although a number of crystal structures have been determined for members of the nitroreductase group, no structures have been reported for reduced enzymes. Upon reduction of NR, there is an increase in the butterfly bend angle of the isoalloxazine ring system (Fig. 6a). Although both oxidized forms have a bend angle of ~16°, the bend in the si direction of the reduced flavin increases to 25°. This extreme conformation places it among the three largest flavin bend angles found in a recent survey of unique flavoprotein structures in the Protein Data Bank (54). The change in bend angle in NR occurs primarily as a rigid motion about the N5-N10 axis, so that each half of the ring system independently superimposes well (r.m.s. of ~0.03 Å) on the oxidized form, but the angle between the two halves has changed. There is considerable disagreement about the equilibrium conformation of the fully reduced anionic flavin (36, 48, 50, 52, 53, 62-64), the form found in reduced NR. Recent theoretical work, however, has predicted a large butterfly bend of 27-29° for this form of free flavin (52, 63, 64). The observed bend of 25° in reduced NR is close to these values suggesting that in the reduced state the protein may not greatly influence the equilibrium conformation of the isoalloxazine system.


View larger version (18K):
[in this window]
[in a new window]
 
Fig. 6.   a, Edge-on view of superimposed FMN groups from the three nitroreductase structures. The oxidized acetate and benzoate complexes are shown in blue and yellow, respectively. The reduced structure is shown in red. b, detail showing the change in N5 position upon reduction.

Residues that interact with the ring system accommodate the increased bend of the reduced flavin by a largely rigid movement of nearby structural elements. The largest shifts of the isoalloxazine ring substituents are ~0.3 Å when oxidized, and reduced flavins are aligned on the center ring (C4a, C5a, C9a, C10a), and the shifts in the nearby protein elements are comparable. Polar groups that interact with the pyrimidine ring and N5 include Lys-14 from the open coil between H1 and H2, and Asn-71 and Lys-74 from H4. On the dimethylbenzene side, Ile-164 from the open coil between S3 and H8, Tyr-144, and Leu-145 from H7 also follow the bend of the flavin. Ser-39 and Ser-40 from the other monomer, which sit over the central ring, move very little upon reduction of the flavin. Proline 163 on the other side of the central ring shifts (by 0.15 Å) parallel to the plane of the ring, presumably as a consequence of the shifts at positions 164 and 165. Any changes in the central ring structure or electronics upon flavin reduction therefore do not result in large rearrangements of protein groups above and below the ring.

The central flavin ring puckers into a boat conformation upon reduction, with N5 moving up and out of the plane formed by the carbons (Fig. 6b). N10 also shifts more out of the plane, but this movement is small relative to the movement of N5. These changes reflect a loss of planarity at the central ring carbons, particularly C4a and C5a, that accompanies the increase in butterfly bending associated with reduction. The amide NH group of Glu-165, which hydrogen bonds with N5 in the oxidized flavin, still participates in this interaction in the reduced form. Glu-165 does not follow the shift in N5, however, and the distance between the two nitrogens increases to 3.22 ± 0.03 Å (average for four monomers in the crystal asymmetric unit) from values of 3.11 ± 0.03 Å and 3.13 ± 0.03 Å for the oxidized acetate and oxidized benzoate complex structures, respectively.

With only this modest accommodation of hydride transfer to N5 in reduced NR, the amide proton of Glu-165 remains in close proximity to the ring nitrogen, well stabilized by a network of interactions that prevent this region of the protein from rearranging. A consequence of this steric restriction is that hydride transfer must occur in the axial position at N5, which adopts sp3 hybridization. Although the overall effect of hydrogen bond donation may be to disfavor protonation at N5 (39, 60, 62, 84-86), participation of the N5 lone pair in the hydrogen bond in the oxidized state should somewhat deshield the axial position, making N5 more susceptible to nucleophilic attack by a reducing substrate positioned above the re face of the flavin. The axial position would also be the correct orientation for direct hydride transfer to an oxidizing substrate located in a similar position. No difference density is present for the hydrogen on N5, but hydrogen density is not expected in a 1.9-Å structure.

Finally, although crystals of NR were grown and reduced in the presence of the same acetate concentration as the acetate complex crystals, the acetate bound over the re side of the flavin is displaced and two ordered solvent molecules now occupy a portion of that volume (Fig. 7). One water molecule is located roughly above N5 near the position of the ligand methyl group in the acetate complex. The other water is located over N10 and C10a, largely overlapping the position of one of the ligand carboxylate oxygens in the acetate complex. The two new solvent molecules in the reduced structure participate in a hydrogen bond network that includes several interactions with nearby protein residues and the flavin (Fig. 7). The solvent molecule above N5 is positioned to make a hydrogen bond interaction via the axial hydrogen at N5, further supporting this position for hydride transfer. This solvent in turn is hydrogen-bonded to the second new water and to the Ogamma of Ser-40. The second water interacts with the amide group of Thr-41 and O2' of the FMN ribose.


View larger version (24K):
[in this window]
[in a new window]
 
Fig. 7.   Electron density on the re side of the reduced flavin. This omit density was averaged over the four unique molecules in the asymmetric unit and contoured at three times the r.m.s. deviation of the map.

There appear to be two factors that contribute to the loss of acetate binding in the reduced enzyme. The axial hydrogen at N5 could clash with the methyl group of bound acetate, reducing affinity. Also, electronic restructuring of the reduced flavin may help to change the binding affinity for organic acids. Koder et al. (15) provide evidence for the anionic hydroquinone form of the flavin in reduced NR, and as noted above, much of the negative electrostatic potential in the anionic form would be predicted to reside in the N1-C2=O2 locus. Because the negatively charged group of these inhibitors is positioned over this locus when bound, it is probable that electrostatic repulsion decreases binding affinity.

NR Redox Properties and Flavin Geometry-- Many aspects of the interaction between flavoproteins and their prosthetic groups are thought to influence the redox properties of the system. In NR, effects that favor reduction must balance those that favor the oxidized form of the flavin, because the Eox/hq of -190 mV is little different from the -208 mV Eox/hq of free flavin (81). The most striking feature of NR is the bent flavin conformation in both oxidation states. Some time ago, Massey and Hemmerich (65), proposed that the conformation adopted by the flavin upon binding to the apoprotein may affect the redox potential of the prosthetic group. Although there has been some controversy over the importance of this effect (54), recent work (54, 63, 64, 66, 67) suggests conformational changes may play a role in determining the redox properties of the protein-flavin system. In oxidized NR, the isoalloxazine ring system is bound in a conformation that is energetically unfavorable in the oxidized free flavin, and this imposed bend may therefore favor reduction. The energetic cost of bending the ring system in free flavin has been variously estimated, but often-quoted studies (36, 63) indicate a value in the range of 6 kcal/mol for a bend equal to the oxidized NR flavin (16°). If an equal cost is incurred in the protein environment, it would translate to an increase of +130 mV in the two electron reduction potential, a substantial effect.

The hallmark of NR redox chemistry is its inability to stabilize the one electron reduced semiquinone form of the flavin (15, 81). Thus, reduction by the second electron is thermodynamically more favorable than the first one electron reduction, which corresponds to a large positive difference between the second and first one-electron redox midpoint potentials, Esq/hq and Eox/sq, of at least +381 mV. The lack of a one electron-reduced state is relatively rare among flavoenzymes, which generally act to stabilize the semiquinone (68, 69). The broad substrate specificity of NR may allow it to fully reduce a number of cellular compounds that might otherwise contribute to oxidative stress via one electron reduction (70). Indeed, the related NfsA has recently been demonstrated (71) to be part of the soxRS regulon in E. coli, which is induced by redox cycling agents.

The hydrogen bond donated to N5 of the flavin may play a role in the lack of semiquinone stabilization. Donation of a hydrogen bond by the protein may disfavor reduction by increasing the cost of protonating N5. In flavodoxin from Clostridium beijerinckii, the interaction of a hydrogen bond acceptor with N5 appears to both increase Eox/sq and decrease Esq/hq to account in part for the strongly stabilized semiquinone in this enzyme (72). Donating a hydrogen bond rather than accepting one might have the opposite effect in NR. It is not apparent, however, why this effect should favor the hydroquinone form over the neutral semiquinone, because both are protonated at N5 and probably carry similar atomic charges at that position (63, 73). Also, it does not explain the absence of the anionic semiquinone, which is not protonated at N5. Old yellow enzyme makes a similar hydrogen bond to N5 of its prosthetic group (74) and yet stabilizes the anionic semiquinone state at the level of 10-20% (75, 76). This enzyme, in fact, makes contacts with its isoalloxazine system that are very similar to those we observe in NR (74). Unlike NR, however, the flavin in old yellow enzyme has only a small butterfly bend in the oxidized state, and this difference may in part explain the different redox properties of the two enzymes. Because all forms of the free semiquinone are believed to be nearly planar (52, 53, 63, 77), the highly bent conformation of the flavin in NR may play a role in its inability to stabilize the one electron reduced form of the prosthetic group. For free flavin, a bend angle of 16°, the conformation in oxidized NR, would destabilize either the neutral or anionic semiquinone forms by ~8 kcal/mol (63), a change in midpoint potential of ~350 mV. This substantial energetic cost may counterbalance the normal tendency toward semiquinone stabilization in the protein environment. The extent of this effect depends on the exact nature of the interaction, however, and a more detailed evaluation of the possible mechanisms of redox tuning in NR raised by the crystal structures reported here must await additional theoretical and experimental studies.

    ACKNOWLEDGEMENTS

We thank Joseph Walsh for helpful discussions and Christina Hines for careful reading of the manuscript.

    FOOTNOTES

* The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

The atomic coordinates and the structure factors (code 1KQC, 1KQB, 1KQD) have been deposited in the Protein Data Bank, Research Collaboratory for Structural Bioinformatics, Rutgers University, New Brunswick, NJ (http://www.rcsb.org/).

Present address: The Johnson Foundation, Dept. of Biochemistry and Biophysics, University of Pennsylvania School of Medicine, Philadelphia, PA 19104.

|| To whom correspondence should be addressed: Dept. of Molecular and Cellular Biochemistry, The University of Kentucky, 800 Rose St., Lexington, KY 40536. Tel.: 859-257-5205; Fax: 859-323-1037; E-mail: rodgers@focus.gws.uky.edu.

Published, JBC Papers in Press, January 22, 2002, DOI 10.1074/jbc.M111334200

2 PDB entry 1NEC; H. J. Hecht, C. Bryant, H. Erdmann, H. Pelletier, and R. Sawaya, unpublished data.

3 Atomic coordinates and structure factors have been deposited with the RCSB Protein Data Bank accession numbers: 1KQC (NR-acetate complex), 1KQB (NR-benzoate complex), 1KQD (reduced NR).

    ABBREVIATIONS

The abbreviations used are: NR, nitroreductase from E. cloacae; NfsA, major oxygen-insensitive NADPH-dependent nitroreductase of E. coli; NTR, minor oxygen-insensitive NAD(P)H-dependent nitroreductase of E. coli; FRase I, major NAD(P)H:FMN oxidoreductase of V. fischeri; NOX, NADH oxidase of T. thermophilus; FRP, NADPH-dependent flavin reductase of V. harveyi; Eox/hq, flavin two-electron reduction midpoint potential relative to the normal hydrogen electrode; Eox/sq, midpoint potential for the oxidized and one-electron reduced pair, Esq/hq, midpoint potential for the one- and two-electron reduced pair; PEG, polyethylene glycol; r.m.s.d., root mean square deviation.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES

1. Spain, J. C. (1995) Annu. Rev. Microbiol. 49, 523-555[CrossRef][Medline] [Order article via Infotrieve]
2. Esteve-Nunez, A., Caballero, A., and Ramos, J. L. (2001) Microbiol. Mol. Biol. Rev. 65, 335-352[Abstract/Free Full Text]
3. Rodgers, J. D., and Bunce, N. J. (2001) Water Res. 35, 2101-2111[Medline] [Order article via Infotrieve]
4. McCalla, D. R., Reuvers, A., and Kaiser, C. (1971) Biochem. Pharmacol. 20, 3532-3537[CrossRef][Medline] [Order article via Infotrieve]
5. Tokiwa, H., and Ohnishi, Y. (1986) Crit. Rev. Toxicol. 17, 23-60[Medline] [Order article via Infotrieve]
6. Rickert, D. E. (1987) Drug. Metab. Rev. 18, 23-53[Medline] [Order article via Infotrieve]
7. Chung, K. T., Murdock, C. A., Zhou, Y., Stevens, S. E., Jr., Li, Y. S., Wei, C. I., Fernado, S. Y., and Chou, M. W. (1996) Environ. Mol. Mutagen. 27, 67-74[CrossRef][Medline] [Order article via Infotrieve]
8. Sera, N., Fukuhara, N., Miyata, N., and Tokiwa, H. (1996) Mutat. Res. 349, 137-144[Medline] [Order article via Infotrieve]
9. Purohit, V., and Basu, A. K. (2000) Chem. Res. Toxicol. 13, 673-692[CrossRef][Medline] [Order article via Infotrieve]
10. Nishino, S. F., and Spain, J. C. (1993) Appl. Environ. Microbiol. 59, 2520-2525[Abstract/Free Full Text]
11. Knox, R. J., Friedlos, F., and Borland, M. P. (1993) Cancer Metastasis Rev. 12, 195-212[CrossRef][Medline] [Order article via Infotrieve]
12. Niculescu-Duvaz, I., Friedlos, F., Niculescu-Duvaz, D., Davies, L., and Springer, C. J. (1999) Anticancer Drug Des. 14, 517-538[Medline] [Order article via Infotrieve]
13. Bryant, C., and DeLuca, M. (1991) J. Biol. Chem. 266, 4119-4125[Abstract/Free Full Text]
14. Bryant, C., Hubbard, L., and McElroy, W. D. (1991) J. Biol. Chem. 266, 4126-4130[Abstract/Free Full Text]
15. Koder, R. L., and Miller, A.-F. (1998) Biochim. Biophys. Acta 1387, 395-405[CrossRef][Medline] [Order article via Infotrieve]
16. Rafii, F., and Hansen, E. B. (1998) Antimicrob. Agents Chemother. 42, 1121-1126[Abstract/Free Full Text]
17. Zenno, S., Saigo, K., Kanoh, H., and Inouye, S. (1994) J. Bacteriol. 176, 3536-3543[Abstract/Free Full Text]
18. Zenno, S., Koike, M., Tanokura, M., and Saigo, K. (1996) J. Biochem. (Tokyo) 120, 736-744[Abstract/Free Full Text]
19. Inouye, S. (1994) DEBS Lett. 347, 163-168
20. Park, H. J., Reiser, C. O., Kondruweit, H., Erdmann, R. D., and Schmid, M. (1992) Eur. J. Biochem. 205, 881-885[Medline] [Order article via Infotrieve]
21. Park, H. J., Kreutzer, R., Reiser, C. O., and Sprinzl, M. (1993) Eur. J. Biochem. 211, 909[Medline] [Order article via Infotrieve]
22. Zenno, S., Koike, H., Kumar, A. N., Jayaraman, R., Tanokura, M., and Saigo, K. (1996) J. Bacteriol. 178, 4508-4514[Abstract/Free Full Text]
23. Lei, B., Liu, M., Huang, S., and Tu, S.-C. (1994) J. Bacteriol. 176, 3552-3558[Abstract/Free Full Text]
24. Hecht, H. J., Erdmann, H., Park, H.-J., Sprinzl, M., and Schmid, R. D. (1995) Nat. Struct. Biol. 2, 1109-1114[CrossRef][Medline] [Order article via Infotrieve]
25. Tanner, J. J., Lei, B., Tu, S.-C., and Krause, K. L. (1996) Biochemistry 35, 13531-13539[CrossRef][Medline] [Order article via Infotrieve]
26. Koike, H., Sasaki, H., Kobori, T., Zenno, S., Saigo, K., Murphy, M. E., Adman, E. T., and Tanokura, M. (1998) J. Mol. Biol. 280, 259-273[CrossRef][Medline] [Order article via Infotrieve]
27. Parkinson, G. P., Skelly, J. V., and Neidle, S. (2000) J. Med. Chem. 43, 3624-3631[CrossRef][Medline] [Order article via Infotrieve]
28. Kobori, T., Sasaki, H., Lee, W. C., Zenno, S., Saigo, K., Murphy, M. E., and Tanokura, M. (2001) J. Biol. Chem. 276, 2816-2823[Abstract/Free Full Text]
29. Lovering, A. L., Hyde, E. I., Searle, P. F., and White, S. A. (2001) J. Mol. Biol. 309, 203-213[CrossRef][Medline] [Order article via Infotrieve]
30. Koder, R. L., and Miller, A.-F. (1998) Protein Expr. Purif. 13, 53-60[CrossRef][Medline] [Order article via Infotrieve]
31. Rodgers, D. W. (1997) Methods Enzymol. 276, 183-203[CrossRef]
32. Otwinowski, Z., and Minor, W. (1997) Methods Enzymol. 276, 307-326[CrossRef]
33. CCP4. (1994) Acta Crystallogr. Sect. D Biol. Crystallogr. 50, 760-763[CrossRef][Medline] [Order article via Infotrieve]
34. Brünger, A. T., Adams, P. D., Clore, G. M., Delano, W. L., Gros, P., Grosse-Kunstleve, R. W., Jiang, J. S., Kuszewski, J. N., Pannu, N. S., Reed, R. J., Rice, L. M., Simonson, T., and Warren, G. L. (1998) Acta Crystallogr. Sect. D Biol. Crystallogr. 54, 905-921[CrossRef][Medline] [Order article via Infotrieve]
35. Kleywegt, G. J., and Jones, T. A. (1998) Acta Crystallogr. Sect. D Biol. Crystallogr. 54, 1119-1131[CrossRef][Medline] [Order article via Infotrieve]
36. Dixon, D. A., Lindner, D. L., Branchaud, B., and Lipscomb, W. N. (1979) Biochemistry 18, 5770-5775[CrossRef][Medline] [Order article via Infotrieve]
37. Jones, T. A., Zou, J. Y., Cowan, S. W., and Kjeldgaard, M. (1991) Acta Crystallogr. Sect. A 47, 110-119
38. Michael, N. P., Brehm, J. K., Anlezark, G. M., and Minton, N. P. (1994) FEMS Microbiol. Lett. 124, 195-202[CrossRef][Medline] [Order article via Infotrieve]
39. Watanabe, M., Ishidate, M., Jr., and Nohmi, T. (1990) Nucleic Acids Res. 18, 1059[Free Full Text]
40. Fraaije, M. W., and Mattevi, A. (2000) Trends Biochem. Sci. 25, 126-132[CrossRef][Medline] [Order article via Infotrieve]
41. Ghisla, S., and Massey, V. (1989) Eur. J. Biochem. 181, 1-17[Medline] [Order article via Infotrieve]
42. Breinlinger, E. C., Keenan, C. J., and Rotello, V. M. (1998) J. Am. Chem. Soc. 120, 8606-8609[CrossRef]
43. Truss, B. L., and Fritchie, C. J. J. (1969) Acta Crystallogr. Sect. B Struct. Sci. 25, 1911-1918[CrossRef]
44. Norrestram, R., and Stensland, B. (1972) Acta Crystallogr. Sect. B Struct. Sci. 28, 440-447[CrossRef]
45. Kuo, M. C., Dunn, B. R., and Fritchie, C. J. J. (1974) Acta Crystallogr. Sect. B Struct. Sci. 30, 1766-1771[CrossRef]
46. Porter, D. J. T., and Voet, D. (1978) Acta Crystallogr. Sect. B Struct. Sci. 34, 598-610[CrossRef]
47. Fritchie, C. J. J., and Johnston, R. M. (1975) Acta Crystallogr. Sect. B Struct. Sci. 31, 454-461[CrossRef]
48. Moonen, C. T. W., Vervoort, J., and Müller, F. (1984) Biochemistry 23, 4859-4867[CrossRef][Medline] [Order article via Infotrieve]
49. Wouters, J., Moureau, F., Perpète, P., Norberg, B., Evard, G., and Durant, F. (1994) J. Chem. Crystallogr. 24, 607-614[CrossRef]
50. Hall, L. H., Orchard, B. J., and Tripathy, S. K. (1987) Int. J. Quant. Chem. 31, 195-216[CrossRef]
51. Platenkamp, R. J., Palmer, M. H., and Visser, A. J. W. G. (1987) Eur. Biophys. J. 14, 393-402
52. Meyer, M., Hartwig, H., and Schomburg, D. (1996) J. Mol. Struct. (Theochem) 364, 139-149[CrossRef]
53. Zheng, Y.-J., and Ornstein, R. L. (1996) J. Am. Chem. Soc. 118, 9402-9408[CrossRef]
54. Lennon, B. W., Williams, C. H., and Ludwig, M. L. (1999) Protein Sci. 8, 2366-2379[Medline] [Order article via Infotrieve]
55. Müller, Y. A., Schumacher, G., Rudolph, R., and Schulz, G. E. (1994) J. Mol. Biol. 237, 315-335[CrossRef][Medline] [Order article via Infotrieve]
56. McGaughey, G. B., Gagné, M., and Rappé, A. K. (1998) J. Biol. Chem. 273, 15458-15463[Abstract/Free Full Text]
57. Pai, E., Karplus, P. A., and Schulz, G. E. (1988) Biochemistry 27, 4465-4474[CrossRef][Medline] [Order article via Infotrieve]
58. Karplus, P. A., and Schulz, G. E. (1989) J. Mol. Biol. 210, 163-180[CrossRef][Medline] [Order article via Infotrieve]
59. Li, R., Bianchet, M. A., Talalay, P., and Amzel, L. M. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 8846-8850[Abstract/Free Full Text]
60. Zenno, S., Koike, H., Tanokura, M., and Saigo, K. (1996) J. Bacteriol. 178, 4731-4733[Abstract/Free Full Text]
61. Isaya, G., Kalousek, F., Fenton, W. A., and Rosenberg, L. E. (1991) J. Cell Biol. 113, 65-76[Abstract/Free Full Text]
62. Moonen, C. T. W., Vervoort, J., and Müller, F. (1984) Biochemistry 23, 4868-4872[CrossRef][Medline] [Order article via Infotrieve]
63. Nakai, S., Yoneda, F., and Yamabe, T. (1999) Theor. Chem. Acc. 103, 109-116[CrossRef]
64. Cavelier, G., and Amzel, L. M. (2001) Proteins 43, 420-432[CrossRef][Medline] [Order article via Infotrieve]
65. Massey, V., and Hemmerich, P. (1980) Biochem. Soc. Trans. 8, 246-257[Medline] [Order article via Infotrieve]
66. Hasford, J. J., Kemnitzer, W., and Rizzo, C. J. (1997) J. Org. Chem. 62, 5244-5245[CrossRef]
67. Trickey, P., Basran, J., Lian, L.-Y., Chen, Z.-W., Barton, J. D., Sutcliffe, M. J., Scrutton, N. S., and Matthews, F. S. (2000) Biochemistry 39, 7678-7688[CrossRef][Medline] [Order article via Infotrieve]
68. Massey, V., Müller, F., Feldberg, R., Schuman, M., Sullivan, P. A., Howell, L. G., Mayhew, S. G., Matthews, R. G., and Foust, G. P. (1969) J. Biol. Chem. 244, 3999-4006[Abstract/Free Full Text]
69. Tedeschi, G., Chen, S., and Massey, V. (1995) J. Biol. Chem. 270, 1198-1204[Abstract/Free Full Text]
70. Prochaska, K. J., and Talalay, P. (1991) in Oxidative Stress: Oxidants and Antioxidants (Sies, H., ed) , pp. 195-211, Academic Press, Ltd., New York
71. Liochev, S. I., Hausladen, A., and Fridovich, I. (1999) Proc. Natl. Acad. Sci. U. S. A. 96, 3537-3539[Abstract/Free Full Text]
72. Ludwig, M. L., Pattridge, K. A., Metzger, A. L., Dixon, M. M., Eren, M., Feng, Y., and Swenson, R. (1997) Biochemistry 36, 1259-1280[CrossRef][Medline] [Order article via Infotrieve]
73. Vazquez, S. A., Andresw, J. S., Murray, C. W., Amos, R. D., and Handy, N. C. (1992) J. Chem. Soc. Perkin Trans. 2 6, 889-895[CrossRef]
74. Fox, K. M., and Karplus, P. A. (1994) Structure 2, 1089-1105[Medline] [Order article via Infotrieve]
75. Stewart, R. C., and Massey, V. (1985) J. Biol. Chem. 260, 13639-13647[Abstract/Free Full Text]
76. Murthy, Y. V. S. N., and Massey, V. (1996) J. Biol. Chem. 271, 19915-19921[Abstract/Free Full Text]
77. Müller, F. (1991) in Chemistry and Biochemistry of Flavoenzymes (Müller, F., ed), Vol. 1 , pp. 2-72, CRC Press, Boca Raton
78. Carson, M. (1987) J. Mol. Graphics 5, 103-106
79. Guex, N., and Peitsch, M. C. (1997) Electrophoresis 18, 2714-2723[CrossRef][Medline] [Order article via Infotrieve]
80. Bryant, C. P. (1990) A Biochemical and Biophysical Investigation of Enterobacter cloacae NitroreductasePh.D. thesis , University of California at San Diego, San Diego, CA
81. Koder, R. L. (1999) Purification, Cloning, and Characterization of an Oxygen-insensitive NAD(P)H Nitroreductase from Enterobacter cloacae Strain 96-3Ph.D. thesis , The Johns Hopkins University, Baltimore, MD


Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
S. R. Thomas, P. M. McTamney, J. M. Adler, N. LaRonde-LeBlanc, and S. E. Rokita
Crystal Structure of Iodotyrosine Deiodinase, a Novel Flavoprotein Responsible for Iodide Salvage in Thyroid Glands
J. Biol. Chem., July 17, 2009; 284(29): 19659 - 19667.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
J. C. Moreno, W. Klootwijk, H. van Toor, G. Pinto, M. D'Alessandro, A. Leger, D. Goudie, M. Polak, A. Gruters, and T. J. Visser
Mutations in the Iodotyrosine Deiodinase Gene and Hypothyroidism
N. Engl. J. Med., April 24, 2008; 358(17): 1811 - 1818.
[Abstract] [Full Text] [PDF]


Home page
J. Bacteriol.Home page
H. Iwaki, T. Muraki, S. Ishihara, Y. Hasegawa, K. N. Rankin, T. Sulea, J. Boyd, and P. C. K. Lau
Characterization of a Pseudomonad 2-Nitrobenzoate Nitroreductase and Its Catabolic Pathway-Associated 2-Hydroxylaminobenzoate Mutase and a Chemoreceptor Involved in 2-Nitrobenzoate Chemotaxis
J. Bacteriol., May 1, 2007; 189(9): 3502 - 3514.
[Abstract] [Full Text] [PDF]


Home page
MutagenesisHome page
S.G. Salamanca-Pinzon, R. Camacho-Carranza, S.L. Hernandez-Ojeda, and J.J. Espinosa-Aguirre
Nitrocompound activation by cell-free extracts of nitroreductase-proficient Salmonella typhimurium strains
Mutagenesis, November 1, 2006; 21(6): 369 - 374.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. van den Hemel, A. Brige, S. N. Savvides, and J. Van Beeumen
Ligand-induced Conformational Changes in the Capping Subdomain of a Bacterial Old Yellow Enzyme Homologue and Conserved Sequence Fingerprints Provide New Insights into Substrate Binding
J. Biol. Chem., September 22, 2006; 281(38): 28152 - 28161.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Ito, M. Nakanishi, W.-C. Lee, H. Sasaki, S. Zenno, K. Saigo, Y. Kitade, and M. Tanokura
Three-dimensional Structure of AzoR from Escherichia coli: AN OXIDEREDUCTASE CONSERVED IN MICROORGANISMS
J. Biol. Chem., July 21, 2006; 281(29): 20567 - 20576.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. R. Race, A. L. Lovering, R. M. Green, A. Ossor, S. A. White, P. F. Searle, C. J. Wrighton, and E. I. Hyde
Structural and Mechanistic Studies of Escherichia coli Nitroreductase with the Antibiotic Nitrofurazone: REVERSED BINDING ORIENTATIONS IN DIFFERENT REDOX STATES OF THE ENZYME
J. Biol. Chem., April 8, 2005; 280(14): 13256 - 13264.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/13/11513    most recent
M111334200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Haynes, C. A.
Right arrow Articles by Rodgers, D. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Haynes, C. A.
Right arrow Articles by Rodgers, D. W.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement